Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | RAD51D |
Variant | S298Y |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | RAD51D S298Y does not lie within any known functional domains of the Rad51d protein (UniProt.org). S298Y has not been characterized in the scientific literature and therefore, its effect on Rad51d protein function is unknown (PubMed, Dec 2024). |
Associated Drug Resistance | |
Category Variants Paths |
RAD51D mutant RAD51D S298Y |
Transcript | NM_002878.4 |
gDNA | chr17:g.35101211G>T |
cDNA | c.893C>A |
Protein | p.S298Y |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_002878.3 | chr17:g.35101211G>T | c.893C>A | p.S298Y | RefSeq | GRCh38/hg38 |
NM_002878 | chr17:g.35101211G>T | c.893C>A | p.S298Y | RefSeq | GRCh38/hg38 |
NM_002878.4 | chr17:g.35101211G>T | c.893C>A | p.S298Y | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
RAD51D mutant | breast cancer | not applicable | N/A | Guideline | Risk Factor | Germline RAD51D mutations are associated with increased risk of developing breast cancer (NCCN.org). | detail... |
RAD51D mutant | ovarian cancer | not applicable | N/A | Guideline | Risk Factor | Germline RAD51D mutations are associated with increased risk of developing ovarian cancer (NCCN.org). | detail... |